259 related articles for article (PubMed ID: 17581991)
1. Expression and characterization of a minimal hepatitis C virus glycoprotein E2 core domain that retains CD81 binding.
McCaffrey K; Boo I; Poumbourios P; Drummer HE
J Virol; 2007 Sep; 81(17):9584-90. PubMed ID: 17581991
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal Antibodies Directed toward the Hepatitis C Virus Glycoprotein E2 Detect Antigenic Differences Modulated by the N-Terminal Hypervariable Region 1 (HVR1), HVR2, and Intergenotypic Variable Region.
Alhammad Y; Gu J; Boo I; Harrison D; McCaffrey K; Vietheer PT; Edwards S; Quinn C; Coulibaly F; Poumbourios P; Drummer HE
J Virol; 2015 Dec; 89(24):12245-61. PubMed ID: 26378182
[TBL] [Abstract][Full Text] [Related]
3. The variable regions of hepatitis C virus glycoprotein E2 have an essential structural role in glycoprotein assembly and virion infectivity.
McCaffrey K; Gouklani H; Boo I; Poumbourios P; Drummer HE
J Gen Virol; 2011 Jan; 92(Pt 1):112-21. PubMed ID: 20926639
[TBL] [Abstract][Full Text] [Related]
4. A conserved Gly436-Trp-Leu-Ala-Gly-Leu-Phe-Tyr motif in hepatitis C virus glycoprotein E2 is a determinant of CD81 binding and viral entry.
Drummer HE; Boo I; Maerz AL; Poumbourios P
J Virol; 2006 Aug; 80(16):7844-53. PubMed ID: 16873241
[TBL] [Abstract][Full Text] [Related]
5. Characterization of modified hepatitis C virus E2 proteins expressed on the cell surface.
Forns X; Allander T; Rohwer-Nutter P; Bukh J
Virology; 2000 Aug; 274(1):75-85. PubMed ID: 10936090
[TBL] [Abstract][Full Text] [Related]
6. Mutations within the CD81-binding sites and hypervariable region 2 of the envelope 2 protein: correlation with treatment response in hepatitis C virus-infected patients.
Hofmann WP; Sarrazin C; Kronenberger B; Schönberger B; Bruch K; Zeuzem S
J Infect Dis; 2003 Mar; 187(6):982-7. PubMed ID: 12660945
[TBL] [Abstract][Full Text] [Related]
7. Mutations in the putative HCV-E2 CD81 binding regions and correlation with cell surface CD81 expression.
Kronenberger B; Sarrazin C; Hofmann WP; von Wagner M; Herrmann E; Welsch C; Elez R; Rüster B; Piiper A; Zeuzem S
J Viral Hepat; 2004 Jul; 11(4):310-8. PubMed ID: 15230853
[TBL] [Abstract][Full Text] [Related]
8. Characterisation of the differences between hepatitis C virus genotype 3 and 1 glycoproteins.
Shaw ML; McLauchlan J; Mills PR; Patel AH; McCruden EA
J Med Virol; 2003 Jul; 70(3):361-72. PubMed ID: 12766998
[TBL] [Abstract][Full Text] [Related]
9. Determinants of CD81 dimerization and interaction with hepatitis C virus glycoprotein E2.
Drummer HE; Wilson KA; Poumbourios P
Biochem Biophys Res Commun; 2005 Mar; 328(1):251-7. PubMed ID: 15670777
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus envelope protein E2 binds to CD81 of tamarins.
Allander T; Forns X; Emerson SU; Purcell RH; Bukh J
Virology; 2000 Nov; 277(2):358-67. PubMed ID: 11080483
[TBL] [Abstract][Full Text] [Related]
11. Delineation of regions important for heteromeric association of hepatitis C virus E1 and E2.
Yi M; Nakamoto Y; Kaneko S; Yamashita T; Murakami S
Virology; 1997 Apr; 231(1):119-29. PubMed ID: 9143310
[TBL] [Abstract][Full Text] [Related]
12. Characterisation of bacterially expressed structural protein E2 of hepatitis C virus.
Yurkova MS; Patel AH; Fedorov AN
Protein Expr Purif; 2004 Sep; 37(1):119-25. PubMed ID: 15294289
[TBL] [Abstract][Full Text] [Related]
13. Construction and characterization of chimeric hepatitis C virus E2 glycoproteins: analysis of regions critical for glycoprotein aggregation and CD81 binding.
Patel AH; Wood J; Penin F; Dubuisson J; McKeating JA
J Gen Virol; 2000 Dec; 81(Pt 12):2873-2883. PubMed ID: 11086118
[TBL] [Abstract][Full Text] [Related]
14. An Optimized Hepatitis C Virus E2 Glycoprotein Core Adopts a Functional Homodimer That Efficiently Blocks Virus Entry.
McCaffrey K; Boo I; Owczarek CM; Hardy MP; Perugini MA; Fabri L; Scotney P; Poumbourios P; Drummer HE
J Virol; 2017 Mar; 91(5):. PubMed ID: 28031364
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal Sequence and Functional Evolution within Glycoprotein E2 in Hepatitis C Virus Genotype 3a Infection.
Alhammad YM; Maharajh S; Butcher R; Eden JS; White PA; Poumbourios P; Drummer HE
PLoS One; 2015; 10(5):e0126397. PubMed ID: 25970466
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus glycoprotein E2 binding to CD81: the role of E1E2 cleavage and protein glycosylation in bioactivity.
Chan-Fook C; Jiang WR; Clarke BE; Zitzmann N; Maidens C; McKeating JA; Jones IM
Virology; 2000 Jul; 273(1):60-6. PubMed ID: 10891408
[TBL] [Abstract][Full Text] [Related]
17. CD81 binding regions of hepatitis C virus remain conserved after liver transplantation.
Lyra AC; Fan X; Di Bisceglie AM
Braz J Infect Dis; 2004 Apr; 8(2):126-32. PubMed ID: 15361990
[TBL] [Abstract][Full Text] [Related]
18. Selection of a phage-displayed peptide recognized by monoclonal antibody directed blocking the site of hepatitis C virus E2 for human CD81.
Cao J; Liao XL; Wu SM; Zhao P; Zhao LJ; Wu WB; Qi ZT
J Microbiol Methods; 2007 Mar; 68(3):601-4. PubMed ID: 17178166
[TBL] [Abstract][Full Text] [Related]
19. Evidence for a polytopic form of the E1 envelope glycoprotein of Hepatitis C virus.
Migliaccio CT; Follis KE; Matsuura Y; Nunberg JH
Virus Res; 2004 Sep; 105(1):47-57. PubMed ID: 15325080
[TBL] [Abstract][Full Text] [Related]
20. Conservation of the conformation and positive charges of hepatitis C virus E2 envelope glycoprotein hypervariable region 1 points to a role in cell attachment.
Penin F; Combet C; Germanidis G; Frainais PO; Deléage G; Pawlotsky JM
J Virol; 2001 Jun; 75(12):5703-10. PubMed ID: 11356980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]